You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: January 7, 2025

Details for Patent: 9,248,148


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 9,248,148 protect, and when does it expire?

Patent 9,248,148 protects ACCRUFER and is included in one NDA.

This patent has ten patent family members in eight countries.

Summary for Patent: 9,248,148
Title:Mono (iron hydroxypyrone) and combination (iron hydroxypyrone and GI inflammation inhibiting agents) compositions for anaemia or H. pylori infections
Abstract: There is provided a composition or kit of parts comprising: one or more compounds capable of treating and/or preventing an inflammatory disease of the gastrointestinal tract: and an iron hydroxypyrone, for increasing the level of iron in a patient's bloodstream and/or treating and/or preventing anaemia such as iron deficiency anaemia. A composition comprising iron hydroxypyrone is also provided for administration to a subject: having or at risk of having achlorhydria; wherein the gastric pH of the subject is equal to or greater than about 4; or wherein the subject has an inflammatory disease of the gastrointestinal tract.
Inventor(s): Stockham; Michael Arthur (Essex, GB)
Assignee: Iron Therapeutics Holdings AG (Wollerau, CH)
Application Number:12/992,528
Patent Claim Types:
see list of patent claims
Use; Composition; Dosage form;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of United States Patent 9,248,148

Introduction

United States Patent 9,248,148, titled "A composition or kit of parts comprising: one or more compounds capable of treating and/or preventing an inflammatory disease of the gastrointestinal tract," is a patent that addresses a specific medical need. To delve into the details of this patent, we need to analyze its scope, claims, and the broader patent landscape it operates within.

Patent Overview

The patent in question, US 9,248,148 B2, was granted for a composition or kit designed to treat or prevent inflammatory diseases of the gastrointestinal tract. Here is a brief overview of the key elements:

  • Publication Number: US9248148B2
  • Prior Art Keywords: Include terms like "iron," "hydroxypyrone," "anaemia," and "gastric," indicating the patent's focus on compounds related to gastrointestinal health[4].

Claims Analysis

The claims of a patent are crucial as they define the scope of the invention and what is protected by the patent.

Independent Claims

Independent claims are those that stand alone and do not depend on other claims. These claims are critical because they define the broadest scope of the invention. For US 9,248,148, the independent claims would typically describe the composition or kit in its most general form, including the active compounds and their intended use.

Dependent Claims

Dependent claims build upon the independent claims and provide more specific details. These claims might include variations of the composition, specific dosages, methods of administration, or particular compounds within the broader category described in the independent claims.

Patent Scope

The scope of a patent is determined by the language of its claims. Here are some key aspects to consider:

Claim Language and Breadth

The breadth of the claims can significantly impact the patent's scope. For example, if the claims are overly broad, they might encompass a wide range of compounds or methods, potentially leading to disputes over patent validity or infringement. The USPTO and courts have been grappling with issues of patent scope, particularly in areas like software and biotechnology, where broad claims can stifle innovation[3].

Independent Claim Length and Count

Research has shown that metrics such as independent claim length and count can be useful in measuring patent scope. Longer independent claims and a higher count of such claims can indicate a broader patent scope, which may be more contentious in terms of validity and enforceability[3].

Inventorship and Ownership

Determining the true and only inventors is crucial for the validity and enforceability of a patent.

Conception and Reduction to Practice

Inventorship is determined by who conceived the idea and reduced it to practice. For US 9,248,148, the inventors listed would have had to conceive the specific compounds and their application in treating gastrointestinal diseases and then reduce this idea to a working example[5].

Joint Inventorship

If multiple individuals contributed to the invention, they would be considered joint inventors. Each joint inventor must have made a significant contribution to at least one claim of the patent[5].

Patent Landscape and Jurisprudence

The broader patent landscape, particularly in the United States, has seen significant changes and challenges in recent years.

Subject Matter Eligibility

The Supreme Court's decisions between 2010 and 2014 have significantly impacted patent eligibility law, leading to increased uncertainty and a heightened bar for patent subject matter eligibility. This has affected various technologies, including those related to healthcare and biotechnology[1].

Public Views and Impact

The USPTO has solicited public comments on the current state of patent eligibility jurisprudence, highlighting concerns about consistency, clarity, and the impact on innovation in key technologies. Stakeholders have expressed that the current jurisprudence has created inconsistencies, uncertainty, and unpredictability in the issuance and enforcement of patent rights[1].

Economic and Innovation Impact

The scope and claims of a patent like US 9,248,148 can have significant economic and innovation implications.

Patent Quality and Scope

The quality and scope of patents can influence innovation. Overly broad patents can increase licensing and litigation costs, potentially diminishing incentives for further innovation. Metrics such as independent claim length and count can help in assessing patent quality and scope[3].

Investment and Innovation

The clarity and consistency of patent eligibility jurisprudence can affect investment in research and development. Uncertainty in the patent landscape can deter investors and hinder innovation, particularly in fields like biotechnology and pharmaceuticals[1].

Examples and Statistics

  • Patent Claims Research Dataset: This dataset from the USPTO provides detailed information on claims from US patents and applications, which can be used to analyze trends in patent scope and quality. For instance, the dataset shows that litigated patents often experience longer and more complex prosecutions, indicating a more rigorous evaluation process[2].

  • FTC Report: A 2003 FTC Report highlighted that software and Internet patents were seen as impeding innovation due to their broad and unclear claims. This underscores the importance of clear and specific claims in patents like US 9,248,148[3].

Key Takeaways

  • Claims Analysis: The claims of US 9,248,148 define the scope of the invention and are crucial for determining what is protected.
  • Patent Scope: The breadth of the claims can impact the patent's validity and enforceability.
  • Inventorship: Correctly identifying the true and only inventors is essential for the patent's validity.
  • Patent Landscape: The current jurisprudence on patent eligibility has created uncertainty and affects innovation in various technologies.
  • Economic Impact: The clarity and consistency of patent eligibility can influence investment and innovation.

Frequently Asked Questions (FAQs)

Q: What is the main focus of US Patent 9,248,148? A: The main focus is on a composition or kit of parts comprising compounds capable of treating and/or preventing inflammatory diseases of the gastrointestinal tract.

Q: How are the claims of a patent like US 9,248,148 structured? A: The claims include independent claims that define the broadest scope of the invention and dependent claims that provide more specific details.

Q: Why is determining the true and only inventors important? A: It is crucial for the validity and enforceability of the patent, as incorrect or deceptive inventorship can render the patent unenforceable.

Q: How has recent jurisprudence impacted patent eligibility? A: Recent Supreme Court decisions have created uncertainty and a heightened bar for patent subject matter eligibility, affecting various technologies.

Q: What metrics can be used to measure patent scope? A: Metrics such as independent claim length and count can be used to measure patent scope and assess patent quality.

Cited Sources

  1. USPTO Report to Congress: "Report to Congress - Patent eligible subject matter - USPTO" (2022)
  2. USPTO Patent Claims Research Dataset: "Patent Claims Research Dataset - USPTO" (2017)
  3. Hoover Institution Paper: "Patent Claims and Patent Scope - Hoover Institution" (2016)
  4. Google Patents: "US9248148B2 - Google Patents"
  5. Determining Inventorship for US Patent Applications: "Determining Inventorship for US Patent Applications" (US patent law)

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 9,248,148

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Shield Tx ACCRUFER ferric maltol CAPSULE;ORAL 212320-001 Jul 25, 2019 RX Yes Yes ⤷  Subscribe ⤷  Subscribe METHOD OF TREATING IRON DEFICIENCY ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 9,248,148

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom0808835.3May 15, 2008
PCT Information
PCT FiledMay 14, 2009PCT Application Number:PCT/GB2009/001231
PCT Publication Date:November 19, 2009PCT Publication Number: WO2009/138761

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.